Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



 
683 Capital Management, LLC
 
Signature:Ari Zweiman
Name/Title:Managing Member
Date:11/24/2025
 
683 Capital Partners, LP
 
Signature:Ari Zweiman
Name/Title:Authorized Person
Date:11/24/2025
 
Ari Zweiman
 
Signature:Ari Zweiman
Name/Title:Self
Date:11/24/2025
Exhibit Information

JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Common Stock, par value $0.0001 per share, of Mersana Therapeutics, Inc. dated as of November 24, 2025 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(2) under the Securities Exchange Act of 1934, as amended. Dated: November 24, 2025 683 CAPITAL MANAGEMENT, LLC By: /s/ Ari Zweiman Ari Zweiman, Managing Member 683 CAPITAL PARTNERS, LP By: /s/ Ari Zweiman Ari Zweiman, Authorized Person /s/ Ari Zweiman Ari Zweiman